Citation Sources and Traceability for Chemical

What Data for This Category Looks Like

Data sources for chemical pharmaceutical intelligent due diligence include National Medical Products Administration public review and approval documents, pharmaceutical-related patents from China Patent Announcement, annual and interim reports of listed pharmaceutical companies, trial data from clinical research registration platforms, and industry standard documents from international pharmaceutical associations.

Update rhythms vary across sources. Review documents update according to approval progress. Patents update in real time with new applications. Corporate annual reports are released quarterly or annually.

Most documents use a mixed structured and semi-structured format, including fields such as active ingredient molecular formulas, production process parameters, clinical trial numbers, compliance inspection items, and patent validity periods. Units cover professional measurement standards including mass, volume, pressure, and time.

Constraints Imposed on Citation Traceability Workflows

Professional data sources in the chemical pharmaceutical field are scattered and have diverse formats. This requires citation traceability workflows to cover identification and address information for multiple data source types, to avoid missing traceability details.

Document lengths are typically long. A single patent or clinical report can reach tens of thousands of characters. Chunking and retrieval configurations must balance context completeness and citation accuracy.

Precise matching of professional fields requires traceability to target specific document fragments. This ensures cited content aligns closely with the current query’s professional requirements, and avoids citing irrelevant full document content.

Differences in update frequencies across data sources require traceability information to display data update times, to maintain the timeliness of due diligence reports.

Configuration Settings

Configuration Item	Recommended Value Range	Rationale
`Recall Count`	Top 8-12 results	Professional pharmaceutical documents have dense content. Too many recalled results will occupy excessive context space, while too few will fail to cover key process, compliance, or patent information
`Maximum Chunk Length`	3000-5000 characters	Paragraph logic in pharmaceutical patents, clinical reports and similar documents is tightly linked. Excessively long chunking will damage professional context connections, while excessively short chunking will split complete descriptions of key parameters
`Similarity Threshold`	0.75-0.85	Professional terminology in the pharmaceutical field has high distinctiveness. A threshold that is too low will introduce irrelevant general industry documents, while a threshold that is too high will miss precise data from niche field segments
`Reorder Return Count`	Top 4-6 results	Only the most relevant professional source fragments need to be retained, to avoid redundant non-core document content interfering with the professionalism of due diligence reports
`Maximum Character Count per Citation`	1200-1800 characters	Professional fragments cited in due diligence reports need to fully display process parameters, active ingredient data and similar content. An excessively long count will exceed context limits
`File Parsing Timeout`	120-180 seconds	Parsing large patent documents or clinical data files takes significant time. A timeout that is too short will cause parsing failures, preventing completion of traceability preparation

The parameter values provided on this page are conventional recommendations used as starting points for configuration. Actual values are affected by material form, data volume and business rules. Specific issues require individual analysis. It is recommended to test on your own samples before finalizing settings.

Three Common Misconfigurations

Symptom: Setting Citation Limit to 1500, configuring the knowledge base chunk size to 5000 tokens, but retrieved citation fragments still exceed the character limit, and the recall count does not meet expectations. Cause: The Maximum Character Count per Citation configuration is not set to a reasonable value lower than the chunk size, resulting in chunked single content still exceeding the citation limit. Additionally, the recall count configuration does not match document lengths.
Symptom: The reply does not include the file address or source identifier of the cited document, only displaying text content. Cause: The Enable Citation Traceability configuration item is not enabled, or the storage address field of the file is not bound in the knowledge base metadata.
Symptom: The knowledge base citation source display cannot be hidden, and the citation block always appears on the interface. Cause: The Hide Citation Identifier configuration item is not found, or the Recall Switch is mistakenly used as the display control switch.

How to Verify Correct Configuration

Upload a chemical pharmaceutical patent document or clinical report, trigger knowledge base parsing, and check if the parsed chunk length matches the configured Maximum Chunk Length.
Initiate a search targeting this document, and check if the returned recall count falls within the configured Recall Count range.
Review the citation fragments in the reply, confirm that their character count does not exceed the set Maximum Character Count per Citation.
Toggle the Enable Citation Traceability switch, and confirm that the citation source identifier and file address are displayed or hidden as expected.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-14.